Innovative Bioink Technology Revolutionizes 3D Printing of Blood Vessels
November 28, 2024 - 06:05
Researchers at the University of Twente, Netherlands, have made an advancement in bioprinting technology that could transform how we create vascularized tissues. Their innovative bioink enables precise 3D printing of blood vessels, paving the way for significant improvements in regenerative medicine and tissue engineering. This breakthrough could lead to enhanced methods for developing artificial organs and improving transplant success rates. The technology utilizes DNA-based materials to create a more accurate and functional representation of vascular structures, which are crucial for supplying nutrients and oxygen to tissues. As this research progresses, it holds the potential to greatly impact healthcare and the future of medical treatments.
MORE NEWS
August 4, 2026 - 21:54
HyperSphere brings data neutralization technology to AWS marketplaceHyperSphere Technologies has made its data protection software available to commercial users through the AWS Marketplace. The company`s Data Neutralization Appliance, previously used mainly in...
August 4, 2026 - 10:56
Israeli technology works to prevent aircraft collisions after deadly firefighting crash in AthensA new Israeli-developed system is being pushed forward as a key safety tool for aerial firefighting, following a deadly collision near Athens that killed two pilots last month. The technology,...
August 3, 2026 - 18:15
Exclusive-Citi hires Bank of America’s Rohan Sen to lead technology services bankingCiti has tapped Rohan Sen, a veteran banker from Bank of America, to lead its technology services coverage. The move, confirmed through an internal memo reviewed by reporters, is part of the bank`s...
August 3, 2026 - 01:51
Aehr Test Systems vs. C3.ai: Which Technology Stock Is a Better Buy in 2026?Investors looking at technology stocks for 2026 are often torn between two very different names: Aehr Test Systems and C3.ai. Both carry heavy valuations and both are burning through cash, but that...